SEARCH

SEARCH BY CITATION

References

  • 1
    OIE 2012. Manual of standards for diagnostics tests and vaccines, Equine Influenza. Chapter 2.5.7, 1–14.
  • 2
    Mumford J. Collaborative study for the establishment of three European Pharmacopoeia Biological Reference Preparations for equine influenza horse antiserum. Pharmeuropa 2000; 1:721.
  • 3
    Daly J, Daas A, Behr-Gross ME. Collaborative study for the establishment of a candidate equine influenza subtype 2 American-like strain A/EQ/South Africa/4/03 - horse antiserum biological reference preparation. Pharmeuropa Bio 2007; 1:714.
  • 4
    Mumford JA, Jessett DM, Rollinson EA, Hannant D, Draper ME. Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines. Vet Rec 1994; 134:15862.
  • 5
    Newton JR, Townsend HG, Wood JL, Sinclair R, Hannant D, Mumford JA. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8). Equine Vet J 2000; 32:6574.
  • 6
    Mumford JA. Biology, Epidemiology and Vaccinology of Equine Influenza. Quality Control of Equine Influenza Vaccines, Proceedings of an International Symposium organised by the European Directorate for the Quality of Medicines (EDQM), Council of Europe, Budapest 10–11 December 2001; 7–12.
  • 7
    Daly JM, Sindle T, Tearle J, Barquero N, Newton JR, Corning S. Equine influenza vaccine containing older H3N8 strains offers protection against A/eq/South Africa/4/03 (H3N8) strain in a short-term vaccine efficacy study. Equine Vet J 2007; 39:44650.
  • 8
    Paillot R, Prowse L, Donald C et al. Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding. Vet Immunol Immunopathol 2010; 136:27283.
  • 9
    Paillot R, Prowse L, Montesso F, Huang CM, Barnes H, Escala J. Whole inactivated equine influenza vaccine: efficacy against a representative clade 2 equine influenza virus, IFNgamma synthesis and duration of humoral immunity. Vet Microbiol 2013; 162:396407.
  • 10
    El-Hage CM, Savage CJ, Minke JM, Ficorilli NP, Watson J, Gilkerson JR. Accelerated vaccination schedule provides protective levels of antibody and complete herd immunity to equine influenza. Equine Vet J 2013; 45:2359.
  • 11
    Garner MG, Cowled B, East IJ, Moloney BJ, Kung N. Evaluating the effectiveness of the response to equine influenza in the Australian outbreak and the potential role of early vaccination. Aust Vet J 2011; 89(Suppl 1):1435.
  • 12
    Selleck PW, Kirkland PD. Avian Influenza. In: Sub-Committee on Animal Health Laboratory Standards for Animal Health Committee (www.scahls.org.au). Australian and New Zealand Standard Diagnostic Procedures for Animal Diseases.
  • 13
    Sergeant ES, Kirkland PD, Cowled BD. Field evaluation of an equine influenza ELISA used in New South Wales during the 2007 Australian outbreak response. Prev Vet Med 2009; 92:3825.
  • 14
    Kirkland PD, Delbridge G. Use of a blocking ELISA for antibodies to equine influenza virus as a test to distinguish between naturally infected and vaccinated horses: proof of concept studies. Aust Vet J 2011; 89(Suppl 1):456.
  • 15
    Read AJ, Arzey KE, Finlaison DS et al. A prospective longitudinal study of naturally infected horses to evaluate the performance characteristics of rapid diagnostic tests for equine influenza virus. Vet Microbiol 2012; 156:24655.
  • 16
    Cowled B, Ward MP, Hamilton S, Garner G. The equine influenza epidemic in Australia: spatial and temporal descriptive analyses of a large propagating epidemic. Prev Vet Med 2009; 92:6070.
  • 17
    Gildea S, Arkins S, Walsh C, Cullinane A. A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings-a randomised blind study. Vaccine 2011; 29:921423.
  • 18
    Gildea S, Arkins S, Walsh C, Cullinane A. A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt horses - a randomised blind study. Vaccine 2011; 29:391722.
  • 19
    Cullinane A, Weld J, Osborne M, Nelly M, McBride C, Walsh C. Field studies on equine influenza vaccination regimes in thoroughbred foals and yearlings. Vet J 2001; 161:17485.
  • 20
    Gildea S, Arkins S, Cullinane A. A comparative antibody study of the potential susceptibility of Thoroughbred and non-Thoroughbred horse populations in Ireland to equine influenza virus. Influenza Other Respi Viruses 2010; 4:36372.
  • 21
    Kittelberger R, McFadden AM, Hannah MJ et al. Comparative evaluation of four competitive/blocking ELISAs for the detection of influenza A antibodies in horses. Vet Microbiol 2011; 148:37783.
  • 22
    Paillot R, Hannant D, Kydd JH, Daly JM. Vaccination against equine influenza: quid novi? Vaccine 2006; 24:404761.
  • 23
    Paillot R, Prowse L. ISCOM-matrix-based equine influenza (EIV) vaccine stimulates cell-mediated immunity in the horse. Vet Immunol Immunopathol 2012; 145:51621.
  • 24
    Suarez DL. Overview of avian influenza DIVA test strategies. Biologicals 2005; 33:2216.
  • 25
    Caporale V, Giovannini A, Zepeda C. Surveillance strategies for foot and mouth disease to prove absence of disease and absence of viral circulation. Rev Sci Tech 2012; 31:74759.
  • 26
    Wood JLN. A Review of the history and epidemiology and a description of recent outbreak. [MSc Dissertation]. London: University of London; 1991.